Susceptibility of penicillin-susceptible and -resistant pneumococci to CFC-222, a new fluoroquinolone

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 4, 1998, Pages 527-530

  Kim, Je Hak ^a,b   Kang, Jin Ah ^b   Lee, Younha ^b   Lee, Kwang Hyuk ^b   Lee, Jae Heung ^b   Choi, Eung Chil ^a   Kim, Byong Kak ^a  

^a Seoul National University   (South Korea)

^b CJ Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ECENOFLOXACIN; IMIPENEM; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; STREPTOCOCCUS PNEUMONIAE;

EID: 0031665734     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.4.527     Document Type: Article

References (10)

1. Klugman, K. & Wasas, A. (1995). In-vitro activity of the fluoroquinolone trovafloxacin against penicillin-susceptible and -resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 36, 873-4.
2. Lee, H. J., Park, J. Y., Jang, S. H., Kim, J. H., Kim, E. C. & Choi, K. W. (1995). High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea. Clinical Infectious Diseases 20, 826-35.
3. Friedland, I. R. & McCracken, G. H. (1994). Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New England Journal of Medicine 331, 377-82.
4. Pankuch, G. A., Jacobs, M. R. & Appelbaum, P. C. (1995). Activity of CP-99, 219 compared to DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. Journal of Antimicrobial Chemotherapy 35, 230-2.
5. Kim, J. H., Kang, J. A., Kim, Y. G., Kim, J. W., Lee, J. H., Choi, E. C. & Kim, B. K. (1997). In-vitro and in-vivo antibacterial efficacies of CFC-222, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy 41, 2209-13.
6. Kim, J. H., Kang, J. A., Hong, K. H., Lee, K. H., Song, S. B., Hwang, H. S. et al. (1995). In-vitro antibacterial activity of CFC-222 against penicillin-susceptible and -resistant Streptococcus pneumoniae. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F122, p. 148. American Society for Microbiology, Washington, DC.
7. Kim, Y. G., Hong, K. H., Song, S. B., Lee, J. M., Nishino, T. & Kim, J. H. (1996). Antibacterial efficacy of CFC-222, a new fluoroquinolone, in specialized infection models. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract F-56, p. 109. American Society for Microbiology, Washington, DC.
8. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A3. NCCLS, Villanova, PA.
9. Florez, C. (1992). Susceptibility of Streptococcus pneumoniae to five antibiotics. Journal of Antimicrobial Chemotherapy 30, 727-8.
10. Lee, Y., Kim, D. H., Hwan, J. Y., Yeon, K. J., Ahn, Y., Nam, S. W. et al. (1997). Pharmacokinetics and safety of CFC-222 in healthy volunteers. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract F-171, p. 175. American Society for Microbiology, Washington, DC.